Skip to main content
CTIS.
EU
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
EN — English
BG — Български
CS — Čeština
DA — Dansk
DE — Deutsch
EL — Ελληνικά
ES — Español
ET — Eesti
FI — Suomi
FR — Français
GA — Gaeilge
HR — Hrvatski
HU — Magyar
IT — Italiano
LT — Lietuvių
LV — Latviešu
MT — Malti
NL — Nederlands
PL — Polski
PT — Português
RO — Română
SK — Slovenčina
SL — Slovenščina
SV — Svenska
NO — Norsk
CTIS.
EU
✕
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
Notice
This is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
CTIS.eu
›
Conditions
› Chronic inflammatory demyelinating polyradiculoneuropathy
Chronic inflammatory demyelinating polyradiculoneuropathy
5 total trials
3 recruiting
MedDRA PT
Filter these 5 trials by phase, country, sponsor and more.
Open in Search →
A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Dem …
Recruiting
2024-517450-95-00
5
2025-06-23
"Chronic inflammatory demyelinating polyradiculoneuropathy (C"
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Recruiting
2024-517529-26-00
5
2025-08-04
"Chronic Inflammatory Demyelinating Polyneuropathy"
Efficacy and Safety Study of Nipocalimab for Adults with CIDP
Recruiting
2023-508425-28-00
4
2022-10-24
"Chronic Inflammatory Demyelinating Polyneuropathy"
Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP
Ended
2024-515386-34-00
4
2025-05-29
"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)"
Proof-of-concept study for SAR445088 in chronic inflammatory demyelinating polyneuropathy (CIDP)
Ended
2024-512345-16-00
4
2021-10-13
Showing 1–5 of 5 trials